The Cooper Companies, Inc. $COO Stake Raised by Citizens Financial Group Inc. RI

Key Points

• Citizens Financial Group increased its Cooper Companies stake by 655.1% in the third quarter, bringing its holdings to 78,697 shares valued at approximately $4.62 million. Institutional investors collectively own 24.39% of COO.
• Analyst sentiment remains mixed but leans toward “Hold”: four analysts rate the stock Buy, 13 Hold and two Sell, with an average price target of $68.60. Several firms recently reduced their targets, while Zacks downgraded the stock to Strong Sell.
• Cooper Companies beat quarterly EPS expectations ($1.15 versus $1.12) but reported revenue below estimates at $1.07 billion. The company also authorized a $3 billion share-repurchase program, allowing buybacks of up to 22.7% of outstanding shares.

Citizens Financial Group Inc. RI lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 655.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,697 shares of the medical device company's stock after buying an additional 68,275 shares during the period. Citizens Financial Group Inc. RI's holdings in Cooper Companies were worth $4,619,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Avalon Trust Co bought a new position in Cooper Companies in the 2nd quarter valued at $25,000. SJS Investment Consulting Inc. boosted its position in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock valued at $26,000 after buying an additional 187 shares during the last quarter. Elevation Wealth Partners LLC increased its position in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after purchasing an additional 375 shares during the period. Continuum Advisory LLC acquired a new position in Cooper Companies during the 2nd quarter valued at about $30,000. Finally, J.Safra Asset Management Corp acquired a new stake in shares of Cooper Companies during the 2nd quarter worth approximately $32,000. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $71.00 to $58.00 and set a "neutral" rating for the company in a research note on Thursday, September 10th. Needham & Company LLC decreased their price target on shares of Cooper Companies from $86.00 to $73.00 and set a "buy" rating for the company in a research note on Thursday, September 10th. Zacks Research downgraded shares of Cooper Companies from a "hold" rating to a "strong sell" rating in a research report on Friday, September 11th. Piper Sandler reaffirmed a "neutral" rating on shares of Cooper Companies in a research report on Thursday, October 15th. Finally, UBS Group lowered their target price on shares of Cooper Companies from $75.00 to $66.00 and set a "neutral" rating on the stock in a report on Thursday, September 10th. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $68.60.

Cooper Companies Stock Performance

COO opened at $61.21 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22. The Cooper Companies, Inc. has a 52-week low of $51.01 and a 52-week high of $89.83. The firm has a market cap of $11.64 billion, a P/E ratio of 20.89, a price-to-earnings-growth ratio of 2.49 and a beta of 0.83. The business's fifty day moving average is $61.79 and its 200-day moving average is $65.74.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The company's revenue was up .5% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.

Cooper Companies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 9th that permits the company to buy back $3.00 billion in outstanding shares. This repurchase authorization permits the medical device company to buy up to 22.7% of its shares through open market purchases. Stock repurchase programs are generally a sign that the company's management believes its stock is undervalued.

Insider Activity

In other Cooper Companies news, Director Paul Keel acquired 4,701 shares of Cooper Companies stock in a transaction that occurred on Friday, September 11th. The shares were bought at an average price of $53.18 per share, with a total value of $249,999.18. Following the completion of the purchase, the director directly owned 4,701 shares in the company, valued at $249,999.18. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Lawrence Kurzius bought 10,000 shares of the business's stock in a transaction on Monday, September 14th. The shares were bought at an average cost of $53.91 per share, for a total transaction of $539,100.00. Following the completion of the acquisition, the director directly owned 21,099 shares in the company, valued at approximately $1,137,447.09. This trade represents a 90.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders acquired 34,701 shares of company stock valued at $1,880,039. Insiders own 2.08% of the company's stock.

Cooper Companies Profile

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women's health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women's health.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.